Moonrise Therapeutics
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2019 | 154,027 | 79,106 | 74,921 | 11.8 | — |
| 2020 | 163,403 | 122,937 | 40,466 | 11.5 | — |
| 2021 | 221,617 | 217,430 | 4,187 | 6.8 | 41% |
| 2022 | 213,320 | 214,693 | −1,373 | 6.8 | 49% |
| 2023 | 291,745 | 321,245 | −29,500 | 3.4 | 61% |
In its most recent public year (2023), this organization spent $29,500 more than it brought in. Its reserves stood at about 3.4 months of spending, down from 11.8 in 2019. Staff pay was 61% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works